Title: ‘Beneficial cytotoxic T lymphocytes response derived from irreversible electroporation (IRE- NanoKnife) of pancreatic cancer for improvement of IRE-ablation cancer therapy’.
Share this story
Dr. Jim Xiang awarded a SHRF Collaborative Innovation Development Grant
Dr. Jim Xiang was awarded a 1-year grant from the Saskatchewan Health Research Foundation, together with co-investigators: Drs. Moser, Zhang, Chibbar.